Development of a selective and sensitive high-performance liquid chromatography-tandem mass spectrometry assay to support pharmacokinetic studies of LY-487,379 in rat and marmoset-Reference-Cited by-同舟云学术

Development of a selective and sensitive high-performance liquid chromatography-tandem mass spectrometry assay to support pharmacokinetic studies of LY-487,379 in rat and marmoset

Published:2018-09 Issue: Volume:1093-1094 Page:1-7
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Gaudette Fleur,Hamadjida Adjia^ORCID,Bédard Dominique,Nuara Stephen G.,Gourdon Jim C.,Michaud Véronique,Beaudry Francis,Huot Philippe

Funder

Thermo Scientific

Université de Montréal

Centre Hospitalier de l'Université de Montréal

McGill University

McGill University Health Centre

Natural Sciences and Engineering Research Council of Canada

Parkinson Society Canada

Fonds de Recherche Québec – Santé

Weston Brain Institute

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference24 articles.

1. Metabotropic glutamate receptors and neurodegenerative diseases;Ribeiro;Pharmacol. Res.,2017

2. The metabotropic glutamate receptors: structure, activation mechanism and pharmacology;Pin;Curr Drug Targets CNS Neurol Disord,2002

3. Pharmacology and functions of metabotropic glutamate receptors;Conn;Annu. Rev. Pharmacol. Toxicol.,1997

4. Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?;Nicoletti;Trends Neurosci.,1996

5. Metabotropic glutamate receptors: synaptic modulators and therapeutic targets for neurologic disease;Benarroch;Neurology,2008

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of mGluR2 and mGluR2/3 activators on parkinsonism in the MPTP-lesioned non-human primate;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-20

2. The mGluR2/3 orthosteric agonist LY-404,039 reduces dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-07-06

3. Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset;European Journal of Pharmacology;2023-01

4. Additive effects of mGluR2 positive allosteric modulation, mGluR2 orthosteric stimulation and 5-HT2AR antagonism on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset;Naunyn-Schmiedeberg's Archives of Pharmacology;2021-09-22

5. Selective blockade of the 5-HT3 receptor acutely alleviates dyskinesia and psychosis in the parkinsonian marmoset;Neuropharmacology;2021-01